Associated Papers
Exploring the functional impact of mutational drift in LRRK2 gene and identification of specific inhibitors for the treatment of Parkinson disease.
Nagarajan N et al.
Journal of Cellular Biochemistry, 2018
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
Ross OA et al.
The Lancet. Neurology, 2011
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.
Nuytemans K et al.
Human Mutation, 2010
20506312 (PubMed )
Supplement: humu0031-0763-SD1.pdf
LRRK2 gene variation and its contribution to Parkinson disease.
Paisán-Ruiz C
Human Mutation, 2009
Parkinson's disease and low frequency alleles found together throughout LRRK2.
Paisán-Ruiz C et al.
Annals of Human Genetics, 2009
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.
Greggio E et al.
Asn Neuro, 2009
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
Ross OA et al.
Annals of Neurology, 2008
Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls.
Paisán-Ruíz C et al.
Human Mutation, 2008
Select a paper to view details